Trial
NCT06169826
Histidine Oral Supplementation as a Therapeutic Modality for Alzheimer's Disease
Phase IVWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Wake Forest University Health Sciences
Collaborators
—
Condition
Alzheimer Disease
Intervention
l-Histidine
Why stopped
withdrawn by the PI
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-04-27